Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Developments in Biologicals|November 21, 2001
DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategyA V Hill, W Reece, P Gothard, et al.
Osteoarthritis and Cartilage|August 12, 2022
The impact of waiting time for orthopaedic consultation on pain levels in individuals with osteoarthritis: a systematic review and meta-analysisR K Patten, A Tacey, M Bourke, et al.
Clinical and Experimental Immunology|January 24, 2004
Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The GambiaM Pinder, W H H Reece, M Plebanski, et al.
The Journal of Infectious Diseases|October 9, 1999
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccineA Lalvani, P Moris, G Voss, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
Infection and Immunity|February 21, 2002
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malariaEdwin A M Lee, Dupeh R Palmer, Katie L Flanagan, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
The Journal of Infection|November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 12